市场调查报告书
商品编码
1197603
显微外科器械市场-增长、趋势、COVID-19 影响和预测 (2023-2028)Microsurgical Instruments Market - Growth, Trends, and Forecasts (2023 - 2028) |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
在预测期内 (2023-2028),显微外科器械市场预计将以 5.1% 的复合年增长率增长。
COVID-19 大流行对世界各地的所有行业产生了重大影响,尤其是医疗保健系统,它不仅影响了感染 COVID-19 的患者,还影响了其他患者,取消和重新安排手术以管理和确保安全急救资源以及许多医院的外科医生短缺也影响了显微外科器械市场。 例如,根据 2021 年 12 月于 2020 年 3 月至 2020 年 4 月在美国发表的题为“美国外科手术趋势和医疗保健系统对政策限制选择性外科手术在 COVID-19 大流行期间的反应”的研究,在暂停的第一个时期,手术治疗量下降到基线率的一半左右,在 2020 年 3 月建议暂停择期手术后,总手术量下降了 48%。 数据显示,由于 COVID-19,手术量显着下降,因此 COVID-19 预计将对显微外科器械市场产生重大影响。
随着全球显微外科手术数量的增加,显微外科手术相对于传统外科手术的巨大优势是主要因素之一。 例如,根据一项于 2021 年 6 月发表的题为“使用 Alloderm 治疗美学区局部牙龈退缩的微创显微外科手术与传统手术的随机对照试验”的研究,在放大镜下对根管治疗进行了显微镜检查。发现手术优于传统显微手术,改善牙龈厚度和患者满意度的评估,以及显微手术部位新血管的更快癒合。预计未来显微手术设备的市场规模将继续扩大.
同样,根据 2022 年 5 月发表的“使用高清 3D 外窥镜进行颈椎显微手术:优点和缺点”的研究报告,高清三维 (3D) 内窥镜 (EX) 具有独特的优点舒适,似乎是传统颈椎前路椎间盘切除融合术 (ACDF) 的可靠替代方案。据报导,它还具有作为外科团队有用教育工具的优点。 因此,由于显微外科手术相对于传统手术具有许多优势,显微外科手术的采用预计会增加,这有望增加对显微外科器械的需求,因此在预测期内。市场预计将在
此外,由于慢性病负担不断增加,全球手术数量不断增加,预计将在预测期内促进显微外科器械市场的增长。 例如,2020 年 9 月发表的一项题为“通过列举全民健康覆盖下城市社区的外科手术来估计印度国家外科手术需求”的研究发现,全球约 11% 的疾病负担是手术或麻醉剂治疗,或两者兼而有之,估计需要进行 3,646 次手术才能满足印度人口的手术需求,而全球估计每 100,000 人需要进行 5,000 次手术。据说全年都需要手术。 随着全球外科手术需求的增加,显微手术器械的需求也在增加,市场有望增长。
此外,需要手术治疗的慢性病负担预计会增加,这有望对研究市场产生积极影响。 例如,根据美国疾病控制与预防中心 2022 年 7 月的更新,冠心病是美国最常见的心脏病类型,影响了大约 2010 万 20 岁以上的成年人。 因此,由于上述因素,预计显微外科器械市场将在预测期内增长。 然而,高昂的手术费用预计将在预测期内抑制显微手术器械市场的增长。
由于美容行业的兴起以及人们对自己外表的自我意识不断增强,对重建和整形手术的需求不断增加等因素,预计整形和重建显微外科手术将占该细分市场的最大份额.增加。 例如,根据国际美容整形外科学会(ISAPS)2020年的报告,全球约有1010万例整容手术,其中美国是手术数量最多的国家。 此外,根据美国整形外科学会发布的 2020 年统计数据,2020 年全球共进行了 6,878,486 次重建手术,而 2019 年为 6,652,591 次。 因此,预计全球范围内进行的大量整形和重建手术将推动这一领域的增长。
此外,市场参与者在显微外科器械方面的技术进步以及产品发布、併购和合作等其他业务扩张计划预计将在预测期内推动整形和重建显微外科领域的增长。预计进一步增加。 例如,2020 年 10 月,MMI SpA 在欧洲推出了用于开放式显微外科手术的 Symani 手术系统,据该公司称,Symani 手术系统具有运动缩放和减少震颤的优点,并且手腕器械最少。我有它。 因此,由于上述因素,预计在预测期内,整形和重建显微外科领域将占有很大的市场份额。
在北美地区,由于骨科疾病和神经系统疾病等慢性病患病率上升,老年人口不断增加,以及该地区对整形和重建手术的需求增加等因素,对显微外科手术的需求预计在预测期内将继续增长,预计将占据设备市场的很大份额。 例如,根据加拿大健康信息研究所 2021 年 6 月的一份报告,从 2019 年到 2020 年,加拿大进行了 63,496 例髋关节置换术和 75,073 例膝关节置换术。髋关节置换术平均增加了约 5%。
此外,在国际美容整形外科学会 (ISAPS) 于 2021 年 12 月发布的 2020 年报告中,美国和墨西哥位列整容手术数量最多的前 10 个国家之列。预计看到北美地区对显微外科器械的高需求。
在北美地区,美国有望成为最大的市场。 这是由于该国针对慢性病和美容目的的手术数量很多,慢性病负担不断增加等因素。 例如,根据美国整形外科医师协会(ASPS)2020年的报告,2020年美国约有1560万人接受整容手术,其中230万人接受整容手术,1320万人接受微创美容。如同一材料所示,由于对整容手术的需求增加,在日本进行的手术数量正在增加。
此外,为占领该地区更大的市场而开展的产品发布、併购和合作等企业活动预计将对市场产生重大影响。 例如,2022 年 2 月,瑞典医疗器械製造商 Stille AB 与 Synovis Micro Companies Alliance, Inc 签订独家经销协议,成为美国手术器械的独家经销商。 因此,由于上述因素,预计北美地区在预测期内将在显微外科器械市场占据重要市场份额。
显微外科器械市场竞争适中,由几家主要参与者组成。 从市场份额的角度来看,一些主要参与者目前主导着市场。 一些知名企业正在积极收购其他公司并推出新产品,以巩固其在全球的市场地位。 一些主要参与者是 Olympus Corporation、KLS Martin Group、World Surgical Corporation、ZEISS International 和 Karl Kaps GmbH & Co 等公司。
The microsurgical instruments market is expected to register a CAGR of 5.1% during the forecast period (2023 - 2028).
The COVID-19 pandemic had a significant influence on all the industries throughout the world, especially on the healthcare systems which affected not only the patients infected with COVID-19 but others as well, which resulted in the cancellation or rescheduling of surgeries to manage and reserve the resources for COVID-19 or emergency ones and also, many hospitals have a shortage of surgeons to perform surgeries which also had its effect on the microsurgical instrument market. For instance, according to the research study published in December 2021, titled "Trends in US Surgical Procedures and Health Care System Response to Policies Curtailing Elective Surgical Operations During the COVID-19 Pandemic", in the United States, the surgical treatment volume fell to around half of baseline rates during the initial shutdown period in March through April 2020 and following the recommendation to stop performing elective surgery in March 2020, the volume of all surgical procedures dropped by 48%. This data shows a significant decline in surgical procedures due to COVID-19 and thus, COVID-19 is expected to have a profound impact on the microsurgical instruments market.
The significant advantage of microsurgery over conventional surgical procedures is one of the major factors because of which the number of microsurgical procedures is increasing around the world. For instance, according to a research study published in June 2021, titled "A Randomized Controlled Trial on a Minimally Invasive Microsurgical Versus Conventional Procedure for the Management of Localized Gingival Recession in Esthetic Zone Using Alloderm", under magnification, the microsurgical method for root coverage was found to be superior to the traditional microsurgical method and in addition to enhanced gingival thickness and patient satisfaction ratings, neovascularization at the microsurgical sites healed more quickly.
Similarly, according to a research study published in May 2022, titled "Cervical Spine Microsurgery with the High-Definition 3D Exoscope: Advantages and Disadvantages", it was reported that the high-definition 3-dimensional (3D) exoscope (EX) offers a unique benefit of good comfort and appears to be a secure substitute for conventional anterior cervical discectomy and fusion (ACDF) and it also benefits the surgical team as a useful educational tool. Hence, owing to the many advantages of microsurgical procedures over conventional procedures, the adoption of microsurgical procedures is expected to increase which is expected to increase the demand for microsurgical instruments and, thus, the market is expected to grow over the forecast period.
Furthermore, the increasing number of surgeries around the world owing to the growing burden of chronic diseases is expected to augment the growth of the microsurgical instruments market during the forecast period. For instance, as per the research study published in September 2020, titled "Estimation of the National Surgical Needs in India by Enumerating the Surgical Procedures in an Urban Community Under Universal Health Coverage", about 11% of the global burden of disease requires surgical or anesthesia care or both, and an estimated 3,646 surgeries would be required annually to meet the surgical needs of the Indian population as compared to the global estimate which is 5,000 surgeries per 100,000 people. Thus, with the rising demand for surgical procedures around the world, the demand for microsurgical instruments is expected to which is anticipated to boost the market growth.
In addition, the increasing burden of chronic diseases that require surgical treatment is expected to increase which is expected to have a positive impact on the studied market. for instance, according to the July 2022 update of the Centers for Disease Control and Prevention coronary heart disease is the most common type of heart disease in the United States that affecting about 20.1 million adults aged 20 and older. Hence, owing to the above-mentioned factors, the microsurgical instruments market is expected to grow over the forecast period. However, the high cost associated with the surgery is expected to restrain the growth of the microsurgery instruments market during the forecast period.
The plastic and reconstructive microsurgery segment is expected to hold the largest share in this market segment, owing to the factors such as the growing demand for reconstructive and plastic surgery due to the rise in the aesthetics industry and greater self-awareness among people about their looks. For instance, according to the 2020 report of the International Society for Aesthetic Plastic Surgery (ISAPS), about 10.1 million cosmetic surgical procedures were performed around the world and the United States was the largest country by volume of surgeries. Further, according to the 2020 statistics published by the American Society of Plastic Surgeons, a total of 6,878,486 reconstructive procedures were performed in 2020, globally, as compared to 6,652,591 procedures in 2019. Hence, the high number of plastic and reconstructive surgeries being performed around the world is expected to boost the segment's growth.
Additionally, technological advancement in the microsurgery instruments by the players in the market along with other business expansion initiatives such as product launches, mergers, and acquisitions, and collaboration, among others are further expected to augment growth in the plastic and reconstructive microsurgery segment over the forecast period. For instance, in October 2020, MMI SpA launched Symani Surgical System in Europe for open microsurgical procedures, and as per the company, the Symani Surgical System combines the advantages of motion scaling and tremor reduction with the smallest wristed instrumentation. Therefore, due to the above-mentioned factors, the plastic and reconstructive microsurgery segment is expected to have a significant market share over the forecast period.
North America region is expected to hold a significant share in the microsurgical instruments market over the forecast period due to factors such as the rising prevalence of chronic disorders such as orthopedic disorders, neurological disorders, rising geriatric population, and growing demand for plastic and reconstructive surgeries in the region. For instance, as per the June 2021 report of the Canadian Institute of Health Information, 63,496 hip replacements and 75,073 knee replacements were performed from 2019 to 2020 in Canada, and there was an average increase of about 5% in recent years in the knee and hip replacement procedures in the country.
Also, as per the 2020 report of the International Society for Aesthetic Plastic Surgery (ISAPS) published in December 2021, the United States and Mexico were one of the top ten destinations with the highest number of cosmetic surgeries and hence, the demand for microsurgical instruments is expected to be high in the North America region over the forecast period.
In the North American region, the United States is expected to be the largest market owing to the factors such as a high number of surgeries being performed in the country for chronic diseases as well as cosmetic purposes, the growing burden of chronic diseases, and other factors. For instance, according to the 2020 report of the American Society of Plastic Surgeons (ASPS), about 15.6 million people have undergone cosmetic procedures in the United States, among which 2.3 million were cosmetic surgical procedures and 13.2 million were cosmetic minimally invasive procedures in 2020 and as per the same source, the number of procedures is increasing in the country owing to the increasing demand of the cosmetic surgical procedures.
Furthermore, the company activities such as product launches, mergers and acquisitions, and collaboration to acquire a greater market in the region are further expected to have a significant impact on the market. For instance, in February 2022, Swedish medical device company Stille AB signed an exclusive distribution agreement with Synovis Micro Companies Alliance, Inc, as its exclusive distributor of surgical instruments in the United States. Therefore, due to the above-mentioned factors, the North American region is expected to hold a significant market share in the microsurgery instruments market during the forecast period.
The Microsurgical Instruments market is moderately competitive and consists of a few major players. In terms of market share, a few of the major players are currently dominating the market. And some prominent players are vigorously making acquisitions and new product launches with other companies to consolidate their market positions across the globe. some of the key players are Olympus Corporation, KLS Martin Group, Global Surgical Corporation, ZEISS International, and Karl Kaps GmbH & Co. among others.